The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | Ongoing clinical trials to look out for in lymphoma
Tycel Phillips, MD, City of Hope, Duarte, CA, provides an overview of ongoing trials in lymphoma, including the Phase III SYMPATICO trial (NCT03112174), the Phase III ECHO trial (NCT02972840), and several other trials exploring novel treatment combinations in diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL). This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
